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Background: Previous studies have demonstrated that senescent cancer-associated fibroblasts (CAFs) derived from genetically
unstable oral squamous cell carcinomas (GU-OSCC), unlike non-senescent CAFs from genetically stable carcinomas (GS-OSCC),
promoted keratinocyte invasion in vitro in a paracrine manner. The mechanism by which this occurs is unclear.
Methods: Previous work to characterise the senescent-associated secretory phenotype (SASP) has used antibody arrays,
technology that is limited by the availability of suitable antibodies. To extend this work in an unbiased manner, we used 2D gel
electrophoresis and mass spectroscopy for protein identification. Matrix metalloproteinases (MMPs) were investigated by gelatin
zymography and western blotting. Neutralising antibodies were used to block key molecules in the functional assays of
keratinocyte adhesion and invasion.
Results: Among a variety of proteins that were differentially expressed between CAFs from GU-OSCC and GS-OSCC, MMP-2 was
a major constituent of senescent CAF-CM derived from GU-OSCC. The presence of active MMP-2 was confirmed by gelatine
zymography. MMP-2 derived from senescent CAF-CM induced keratinocyte dis-cohesion and epithelial invasion into collagen
gels in a TGF-b-dependent manner.
Conclusions: Senescent CAFs from GU-OSCC promote a more aggressive oral cancer phenotype by production of active MMP-2,
disruption of epithelial adhesion and induction of keratinocyte invasion.
The acknowledgement that the mesenchymal component of solid
tumours has a critical role in tumour pathogenesis has led to the
concept that epithelial cancers are dysfunctional tissues rather than
simply an accumulation of a critical number of mutations in
tumour cells (Hanahan and Weinberg, 2011). The non-malignant
cells, together with the ECM, constitute the tumour stroma and
pre-eminent in the stroma are cancer-associated fibroblasts (CAFs;
Kalluri and Zeisberg, 2006).
A considerable body of evidence has shown that cellular
senescence acts as a barrier to epithelial malignancy. In oral
squamous cell carcinoma (OSCC), we and others have shown that
the loss of genes such as TP53 and p16INK4A leads to the
development of genetically unstable OSCC (GU-OSCC; Edington
et al, 1995; Loughran et al, 1997; Weber et al, 1998; Hunter et al,
2006; Pickering et al, 2013; Thakker and Parkinson, unpublished
observations). Not all OSCCs, however, are dysfunctional for p53,
and genetically stable carcinomas (GS-OSCC) have been identified
(Agrawal et al, 2011; Stransky et al, 2011; Pickering et al, 2013).
Recently, we isolated CAFs from GU-OSCC and demonstrated that
they had a distinct transcriptional profile that distinguished them
from GS-OSCC CAFs and from normal human oral mucosal
fibroblasts (NHOF; Lim et al, 2011). Further, we have shown that
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CAFs from GU-OSCC have high levels of senescence, a phenotype
that promotes keratinocyte invasion in vitro relative to non-
senescent fibroblasts (Hassona et al, 2013). Similar observations
have been made by others (Krtolica et al, 2001; Pazolli et al, 2009),
and the pro-tumorigenic effect of senescent fibroblasts has been
attributed to the secretion of a myriad of soluble factors, proteases
and non-protein secretions collectively described as the senescent-
associated secretory phenotype (SASP; Coppé et al, 2008; Kuilman
and Peeper, 2009).
Previous work to characterise the SASP showed that the SASP
was not a fixed phenotype but changed according to the fibroblast
strain and culture conditions (Coppé et al, 2008). In these studies,
the constituents of the SASP were quantified using antibody arrays,
technology that is limited by the availability of suitable antibodies.
In the present study, we sought to extend the previous work in an
unbiased manner and used 2D gel electrophoresis and mass
spectroscopy for protein identification. One of the proteins
identified was MMP-2, an interesting finding because we had
previously shown it to be a component of the conditioned medium
(CM) of senescent oral fibroblasts in the premalignant condition
oral submucous fibrosis (Pitiyage et al, 2011), and yet, it had not
been reported as part of the SASP (Coppé et al, 2008). In the
present study, we show that MMP-2 is activated in CAF-CM and
causes epithelial dis-cohesion with subsequent increased invasion
of keratinocytes in vitro in a TGF-b-dependent manner.
MATERIALS AND METHODS
Cell strains and culture conditions. Details of the fibroblast
strains and keratinocyte cell lines have been documented
previously (Lim et al, 2011; Hassona et al, 2013). Fibroblasts were
derived from normal oral mucosa (NHOF1, NHOF2, NHOF6),
genetically stable OSCC (GS-OSCC/BICR66F, GS-OSCC/
BICR73F, GS-OSCC/BICR59F) and genetically unstable OSCC
(GU-OSCC/H357F, GU-OSCC/H314F, GU-OSCC/BICR18F,
GU-OSCC/BICR3F). The keratinocyte cell line used in the
adhesion and invasion assays was H357, because it harbours
TP53 mutations (Yeudall et al, 1995), inactive p16INK4A (Wu et al,
1999) and is non-tumorigenic in vivo (Prime et al, 2004) and non-
invasive in organotypic cultures (Lim et al, 2011).
Fibroblasts were cultured in DMEM supplemented with 10%
(v/v) foetal bovine serum (FBS) and 2mM L-glutamine and grown
in standard conditions (humidified atmosphere of 5% CO2/95% at
37 C1); cells were examined at passages o12. Keratinocytes were
cultured in DMEM-F12 supplemented with 10% (v/v) FBS and
0.5mgml 1 hydrocortisone in standard conditions. In certain
experiments, 1 104 NHOF1 were seeded into 60-mm culture
dishes, grown until 60% confluent and then treated with 600 mM
H2O2 (BDH) for 2 h each day for 5 days. The cells recovered in
fresh culture media for 5 days before analysis. The induction of
senescence was confirmed by upregulation of SA -Gal activity and
p16INK4A, as demonstrated previously (Hassona et al, 2013).
Collection of CM. Cells were grown in 75-cm flasks until they
were 70–90% confluent, washed with serum-free media (3 ) and
PBS (3 ) and then incubated in 7ml serum-free media for a
further 48 h. The CM was centrifuged at 2000 r.p.m. for 5min to
remove dead cells. The viable attached cells were trypsinised and
counted; the CM was normalised to 0.5 106 fibroblasts. CM was
stored at  20C1.
Protein concentration. Fibroblast CM was centrifuged in Cen-
tricon YM-10 centrifugal concentrator units (Millipore (UK) Ltd,
Feltham, Hertfordshire, UK) at 3000 g for 30min in a MSE Mistral
2000 bench top centrifuge. The filtrate was discarded, and the
process was repeated to obtain a volume of approximately 50 ml
(40-fold concentration). The total time of centrifuging ranged from
4 to 5 h. Protein concentration was measured using the Bio-Rad
DC Protein Assay Kit (Bio-Rad, Hemel Hempstead, UK) and
ranged from 0.4 to 1.0 mg ml 1.
2D gel electrophoresis and mass spectrometry. CM were
collected from normal fibroblasts (NHOF1, NHOF 2), normal
fibroblasts treated with H2O2 (FibsþH2O2) and fibroblasts from
genetically stable (GS-OSCC/BICR66F; GS-OSCC/BICR73F) and
unstable (GU-OSCC/BICR18F; GU-OSCC/H357F) OSCC. Sam-
ples were concentrated using Microcon-10 centrifugal filter devices
(Millipore) and washed extensively in 10mM Tris-HCl, pH7 to a
final volume of 50 ml. Concentrated extracts were made up to
200 ml with 7 M Urea, 2 M Thiourea, 4% CHAPS, 0.002%
Bromophenol Blue, 0.5% IPG Buffer pH3-11NL and 1.2% Destreak
reagent (GE Life Sciences, Little Chalfont, Buckinghamshire, UK).
Samples were left at ambient temperature for 1 h and then loaded
on to 11-cm Immobiline DryStrips (first-dimension IPG strips,
pH3-11, non-linear; GE Life Sciences) by passive rehydration.
Following rehydration overnight, isoelectric focussing was per-
formed using the Ettan IPGphor3 (GE Life Sciences), according to
the manufacturer’s instructions. The focussed IPG strips were
incubated for 15min in 10ml SDS equilibration buffer (50mM
Tris-HCl, pH8.8, 6 M urea, 30% glycerol, 2% SDS, 0.002%
bromophenol blue) containing 100mg DTT and then in 10ml
equilibration buffer containing 250mg iodoacetamide for a further
15min. The equilibrated strips were applied to the surface of
vertical 12.5% SDS–polyacrylamide gels, and the proteins were
separated in the second dimension using the Ettan DALT 6
separation unit (GE Life Sciences) at 5mA/gel for 1 h, 8mA/gel for
1 h and then 13W/gel, until completion. The gels were fixed for 1 h
in 50% methanol/10% acetic acid and stained overnight using
Sypro Ruby total protein stain (Life Technologies Ltd, Paisley,
Scotland).
Following de-staining in 10% methanol/7% acetic acid, the gels
were examined using a Typhoon 9400 variable mode imager (GE
Life Sciences). Protein spots of interest were excised from the gel
using the Investigator ProPic automated spot picker and digested
with trypsin using the ProGest automated digestion unit (Perkin
Elmer Life Sciences, Buckinghamshire, UK). The resulting peptides
were analysed using a 4700 MALDI-Tof/Tof mass spectrometer
(Applied Biosystems, Life Technologies Ltd) to give a peptide mass
fingerprint and peptide sequence information. The data were
searched against the NCBInr database using the Mascot search
engine from Matrix Science (London, UK) to identify specific
proteins. Mass spectrometry details were recorded in positive ion
mode on an Applied Biosystems 4700 MALDI mass spectrometer.
MS spectra were recorded in reflector mode. For MSMS analysis,
the top nine most intense, non-tryptic, precursors were selected for
fragmentation by collision-induced dissociation. Neither baseline
subtraction or smoothing were applied to recorded spectra. MS and
MSMS data were analysed using GPS Explorer 3.5 (Applied
Biosystems). MS peaks were filtered with a minimum signal-to-
noise ratio of 35 to exclude mass derived from trypsin autolysis.
MSMS peaks were filtered to exclude peaks with a signal-to-noise
ratio o35 over a mass range of 20–50Da below the precursor
mass. Data were analysed using the MASCOT algorithm (Matrix
Science) and the NCBI database. A maximum number of missed
cleavages of 1 and a charge state of þ 1 were assumed for
precursor ions. A precursor tolerance of 100 p.p.m. and an MS/MS
fragment tolerance of 0.15Da were used in the database search.
Routinely, samples were analysed with methionine oxidation,
considered to be a variable modification.
Zymography. Gelatinase activity and secretion in fibroblast CM
were determined using SDS–polyacrylamide gel zymography
(Cirillo et al, 2007a). Briefly, 20 ml aliquots of CM were mixed
with 20 ml 2 Lemmli sample buffer and heated at 50 1C
for 5min. Samples were electrophoresed on a 10%
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SDS–polyacrylamide gel containing 0.5mgml 1 gelatin. Then the
gels were washed in 2.5% Triton X-100 (3 , each for 10min) to
remove SDS and incubated overnight at 37 1C in substrate buffer
(50mM Tris-HCl, pH 7.8; 10mM CaCl2; 0.1% Triton X-100) to
allow the protease to digest its substrate. The following day, the gels
were washed in distilled H2O and stained with Coumassie Brilliant
Blue R-250 (500ml methanol, 400ml distilled H2O, 100ml glacial
acetic acid, 2.5 g Coumassie Brilliant Blue R-250) and briefly de-
stained in a de-staining solution (785ml distilled H2O, 165ml
ethanol, 50ml glacial acetic acid). Proteolytic activity appeared as
clear bands on a blue background.
Immunoprecipitation (IP) and western blotting (WB). Pelleted
cells were suspended in IP buffer (50mM Tris–HCl, pH 7.5,
150mM NaCl, 0.5% Nonidet P-40, 1mM dithiothreitol, 1mM
PMSF) and centrifuged for 30min at 16 000 g. Supernatants
containing equal amounts of protein (300 mg) were precleared
with 15ml protein A–Sepharose and then incubated for 1 h with a
mouse monoclonal IgG against amino acids 557–569 of MMP-2,
after which 15ml protein A–Sepharose was added for 2 h. After
centrifugation at 2300 g for 10min, beads containing antigen–
antibody complexes were washed, and WB was performed as
detailed (Cirillo et al, 2007b). A goat anti-MMP-2 IgG was used as
a primary antibody in order to reduce cross-reactivity of the
secondary antibody against the Fc fraction of the immunopreci-
pitated anti-MMP-2 IgG of mouse origin. Details of antibodies,
concentrations and suppliers are summarised in Supplementary
Table S1.
Inhibition of MMP-2 and TGF-b. MMP-2 was inhibited by the
addition of anti-MMP-2 monoclonal antibody (4mgml 1, Cat no.
MAB13405; Millipore) to GU-OSCC/H357F cultures before the
collection of CM. To inhibit TGF-b, 5 ml ml 1 monoclonal
antibody to TGF-b1, -b2 and -b3 (Cat no. MAB1835; R & D
Systems, Abingdon, Oxfordshire, UK) was added to the fibroblast
CM for 30min at 37 1C.
Epithelial adhesion. Intercellular adhesion of keratinocytes trea-
ted with fibroblast CM was measured using the Dispase
dissociation assay (Cirillo and Prime, 2009). In all, 1 104
keratinocytes were cultured in six-well plates under standard
conditions until B95% confluent. The culture media were
decanted, the cells washed with PBS (3 ) and then incubated
with 4ml fibroblast CM for 48 h. The fibroblast CM was decanted
from the keratinocyte cultures, and the cells were washed with PBS
(2 ). Then, the keratinocytes were incubated with 2ml 0.5%
Dispase II (Sigma Aldrich Ltd, Gillingham, Dorset, UK) at 37 1C
for 15–20min such that they were separated from the base of the
culture dish as a single sheet. The Dispase was carefully decanted,
and the cell sheet was gently washed with 3ml PBS before
transferring to universal tubes containing 4ml PBS. The tubes were
then sealed and shaken by hand up and down (20 ). The content
of each tube was returned back to the six-well plates where 10 ml
crystal violet was added, and the total number of detached
fragments was counted. The number of detached fragments
(43mm), determined by placing the six-well plate over a grid
on a white paper, was taken as a measure of intercellular
keratinocyte adhesive strength.
Epithelial invasion. Epithelial invasion was examined as described
previously (Tselepis et al, 1985; Hassona et al, 2013). Briefly,
collagen gels were prepared by mixing 4ml 3.75mgml 1 type 1
collagen from rat tail tendon (BD Biosciences, Oxford, UK), 5ml
fibroblast CM and 1ml 0.125M NAOH/0.26M NaHCO3. The
collagen mixture was aliquoted into 24-well plates and allowed to
set for approximately 3 h at 37 1C. In all, 2.5 104 H357 epithelial
cells in 500 ml DMEM-F12/10%FBS were gently layered on top of
the collagen surface, and after 72 h, the gels were gently washed
with PBS, treated with trypsin for 20min under standard conditions
and then the number of trypsinised cells was counted. The collagen gels
were melted by heating on a hot plate for 2–4min at 50 1C, the collagen
was diluted in PBS and the number of cells was counted in this
solution. The invasion index was calculated by dividing the number of
cells in the gel by the number of the cells in trypsin.
Statistics. Unless otherwise indicated, the experiments were
repeated 3 ; the values cited were the mean of the repeats±s.d.
Data were analysed using the one-way analysis of variance with
Tukey’s multiple comparison test being used as a post test. Po0.05
was considered statistically significant.
RESULTS
Protein expression in fibroblast CM. In view of the identification
of the SASP (Coppé et al, 2008), we reasoned that CM from
senescent fibroblasts would show an increased protein concentra-
tion relative to non-senescent cells. The results demonstrated that
when the protein concentration was normalised to cell number,
CM from fibroblasts from GU-OSCC (H357F, H314F, BICR3F)
contained significantly more protein (mean 0.73±0.075 mg ml 1)
than CM from fibroblasts from normal mucosa (NHOF1, NHOF2,
NHOF6; mean 0.26±0.032 mg ml 1) and GS-OSCC (BICR66F,
BICR73F, BICR59F; mean 0.32±0.055 mg ml 1) (Figure 1).
Identification of MMP-2 in senescent fibroblast CM. 2D gel
electrophoresis was used to identify secreted proteins that were
differentially expressed in CM from senescent fibroblasts
(GU-OSCC/H357F, GU-OSCC/BICR18F, H2O2-treated NHOF1)
relative to non-senescent fibroblasts (GS-OSCC/BICR66F,
NHOF1) (Figure 2). Nine spots from the senescent fibroblast gels
that were absent in the non-senescent fibroblast gels were selected
randomly for further analysis using a 4700 MALDI-Tof/Tof mass
spectrometer. The data were searched against the NCBInr Human
database using the Mascot search engine from Matrix Science to
identify specific proteins. Identified proteins with a protein score
above the Mascot-defined significance threshold of 65 are

























Figure 1. Mean protein concentration in fibroblast CM. CM was
collected from normal fibroblasts (NHOF1, NHOF2, NHOF6),
fibroblasts from GS-OSCC (BICR66F, BICR73F, BICR59F) and
fibroblasts from GU-OSCC (H314F, H357F, BICR3F). CM derived from
senescent fibroblasts (GU-OSCC) contained significantly more protein
than non-senescent fibroblasts from normal mucosa and GS-OSCC
(Po0.05).
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MMP-2 was selected for further study because of: (1) its
importance in head and neck cancer (HNSCC; Rosenthal and
Matrisian, 2006); certain MMPs are known to be upregulated in
CAFs from HNSCC (Rosenthal et al, 2004); its expression in the
SASP is controversial (Coppé et al, 2008; Pitiyage et al, 2011).
Function of MMP-2. MMP-2 is secreted as a propeptide and
needs to be cleaved in order to be biologically active. SDS–
polyacrylomide zymography was used to examine MMP-2 activity.
The active form of MMP-2, as demonstrated by the presence of
gelatinolitic activity in the zymograms, was detected in senescent
pH3 pH11








































Figure 2. 2D gel electrophoresis of CM from senescent fibroblasts (H357F; BICR18F; H2O2-treated NHOF1) showed more protein spots than
non-senescent fibroblasts (NHOF1; BICR66F). The protein spots selected for mass spectrometry analyses are outlined in red.
Table 1. Summary of differentially expressed proteins identified in conditioned media from senescent fibroblasts (H357F; BICR18F; H2O2-treated
NHOF1) relative to non-senescent fibroblasts (BICR66F, NHOF1)
Spot









1 H357F Glucose-regulated protein (GRP-78)/heat-shock protein 5 16507237 5.07 72402.5 668
2 H357F Gelatinase A (MMP2) 5822007 5.2 71841.5 623
Collagenase type IV precursor 180671 5.2 73279.2 608
3 H357F Chain A, gelatinase A (MMP2) 5822007 5.2 71841.5 582
Collagenase type IV precursor 180671 5.2 73279.2 580
4 H357F Chain A, human Prommp-1 58176727 6.43 51982.7 511
Chain A, human fibroblasts collagenase 114793614 6.06 42265.6 363
5 H357F ACTB protein 15277503 5.5 40536.2 536
6 BICR18F Secreted protein, acidic, cysteine-rich (SPARC) (osteonictin) 119582071 4.78 36939.7 207
7 BICR18F TIMP-2 119609945 6.81 20695.1 125
8 H202-treated FIB Chain A, human Prommp-1 58176727 6.43 51982.7 499
MMP1 preprotein 62897673 6.57 46691 495
9 H202-treated FIB Hla-A2 229995 6.46 11596.7 69
Hla-B27 230014 6.07 11837.8 69
Chain B, immune receptor 66361122 5.76 12121 68
Abbreviations: FIB¼ fibroblasts; pI¼ isoelectric point; MW¼molecular weight. The protein name and accession number represented the candidate proteins identified with a significant score
from the NCBInr database by the Mascot search engine. The protein score is defined as  10 Log(P), where P is the probability that the observed match is a random event; protein scores465
were considered significant (Po0.05). The theoretical pI and MW (in Daltons) for each identified protein are shown.
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fibroblast CM (GU-OSCC/H357F, GU-OSCC/BICR18F, H2O2-treated
NHOF1) but not in CM from non-senescent fibroblasts
(GS-OSCC/BICR66F, NHOF1), (Figure 3A). The presence of two
bands specific for MMP-2 in the CM, including a B64-Kd band
corresponding to the active form of MMP-2, was confirmed by
western blotting using a monoclonal antibody against MMP-2
(Figure 3B).
Because it has been shown that gelatinases, including MMP-2,
can cleave cell–cell adhesion molecules (Weiske et al, 2001; Cirillo
et al, 2007c) and given the key role of intercellular adhesion in
preventing epithelial invasion (Tselepis et al, 1985; Perl et al, 1998),
we wished to determine whether stromal-derived MMP-2
regulated keratinocyte adhesion and invasion. MMP-2 activity
was virtually inhibited using an anti-MMP-2 monoclonal antibody,
and the absence of active MMP-2 was confirmed using
zymography (Supplementary Figure S1). Inhibition of MMP-2
activity in senescent fibroblast CM (GU-OSCC/H357F) resulted in
a significant (Po0.05) reduction in the capacity of these cells to
induce dissociation of H357 keratinocytes, as demonstrated in the
Dispase dissociation assay (Figure 4A). At the molecular level,
incubation of keratinocytes (H357) with CM from GU-OSCC/
H357F was associated with formation of a 75-kDa proteolytic
fragment of the adhesion molecule DSG3 (Cirillo et al, 2008),
which was partially inhibited by pretreatment with an anti-MMP-2
blocking antibody (Supplementary Figure S2). Similarly, inhibition
of MMP-2 activity in GU-OSCC/H357F resulted in a significant
(Po0.05) reduction in the ability of these senescent fibroblasts to
induce invasion of H357 keratinocytes into collagen gels
(Figure 4B). Inhibition of MMP-2 activity in CM from non-
senescent fibroblasts (NHOF1) had no effect on keratinocyte
dissociation or invasion (Figures 4A and B). Consistent data were
obtained when using different fibroblast cell strains from both
genetically stable and unstable OSCC (Supplementary Figure S3).
MMP-2 acts with TGF-b to promote tumour invasion. We have
shown recently that senescent fibroblasts exert pro-invasive effects
via mechanisms that involve TGF-b (Hassona et al, 2013). In view
of the fact that MMP-2 proteolytically cleaves and activates latent
TGF-b (Yu and Stamenkovic, 2000), we reasoned that stromal-
derived MMP-2 might act in conjunction with TGF-b to promote
keratinocyte invasion. We show that inhibition of both MMP-2
and TGF-b in CM from senescent fibroblasts (GU-OSCC/H357F)
caused more inhibition of keratinocyte invasion compared with
inhibition of either MMP-2 or TGF-b alone (Figure 5). Our data
strongly suggest that MMP-2 and TGF-b operate additively to
disrupt H357 adhesion.
DISCUSSION
In this study, we examined fibroblast CM from a variety of
different fibroblast types and show increased protein concentration
in media derived from senescent CAFs (GU-OSCC) relative to
non-senescent fibroblasts (GS-OSCC CAFs, normal fibroblasts).
The findings support the concept that senescent fibroblasts secrete
a plethora of factors associated with inflammation and malignancy
collectively known as the SASP (Coppé et al, 2008). We used 2D
gel electrophoresis and mass spectrometry to identify key proteins
of the SASP that were differentially expressed between senescent
(GU-OSCC) and non-senescent CAFs (GS-OSCC); H2O2-treated
NHOF1 and untreated NHOF1 were used as positive and negative
controls, respectively. We showed differential expression of
MMP-2, MMP-1, TIMP-2, collagenase, osteonictin, glucose
regulated protein (GRP-78) and ACTB protein (b-actin). Certain
MMPs, osteonictin and TIMP-2 have been reported previously in
senescent cells (Coppé et al, 2008; Dean and Nelson, 2008;
Kuilman & Peeper, 2009), but the identification of GRP-78, a
member of the heat-shock protein-70 (HSP-70) family, was novel.
HSPs are known to be overexpressed in a wide range of human
cancers and have been implicated in the regulation of tumour cell






Figure 3. Gelatin zymography (A) and western blot analysis (B) of CM
from senescent (H357F; BICR18F; H2O2-treated NHOF1) and non-
senescent (BICR66F; NHOF1) fibroblasts. The data show gelatinase
activity (molecular weight 75 Kd) and active MMP-2 (molecular weight















































































Figure 4. Effect of MMP-2 inhibition on the pro-dissociative and pro-invasive effect of CM from senescent fibroblasts(GU-OSCC/H357F) on
H357 keratinocytes. Inhibition of stromal-derived MMP-2 resulted in a significant reduction in the ability of senescent fibroblasts to induce
dissociation of H357 keratinocytes (A) and keratinocyte invasion (B). CM from normal oral fibroblasts (NHOF1) was used as a negative control.
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proliferation, differentiation, invasion and metastasis (Ciocca and
Calderwood, 2005). As far as we are aware, the presence of HSPs
has not been reported in the SASP. Interestingly, non-secreted
proteins such as fibronectin, collagen and laminin have also been
found in the SASP, but the identification of b-actin (ACTB
protein), a cytoskeletal non-secreted protein, is novel. Whether
these non-secreted proteins actively contribute to the ECM or
whether they are simply present as a result of cellular lysis due to
the incubation of cells in serum-free media before culture media
collection is unclear.
MMPs are a diverse group of zinc-dependent endopeptidases
that have importance in HNSCC (Rosenthal and Matrisian, 2006).
In the present study, we demonstrate the presence of active
MMP-2 in CM from senescent fibroblasts using gelatin zymo-
graphy, a highly sensitive technique to analyse MMPs in biological
samples (Hawkes et al, 2001). Although the expression of MMP-2
by senescent fibroblasts is controversial (Coppé et al, 2008; Pitiyage
et al, 2011), recent data indicate that pro-MMP-2 (inactive) is
secreted by CAFs in OSCC (Fullar et al, 2012). In the present
study, we show that the inhibition of MMP-2 activity results in a
decrease in the capacity of senescent fibroblasts to promote
keratinocyte dis-cohesion and invasion in vitro. The results
support the concept that MMP-2 promotes tumour invasion into
collagen gels in vitro by disrupting epithelial adhesion; the findings
extend previous data (Zhang et al, 2006).
Previous studies have shown that TGF-b1 has the capacity to
upregulate MMP-2 (Lin et al, 2007), and conversely, MMP-2 can
activate latent TGF-b (Yu and Stamenkovic, 2000). These findings
prompted us to investigate whether MMP-2 and TGF-b acted in
concert in the stromal regulation of keratinocyte invasion. We
demonstrate that the combined inhibition of MMP-2 and TGF-b
results in a significant reduction in the ability of senescent
fibroblasts to induce keratinocyte invasion into collagen gels
compared with the inhibition of either MMP-2 or TGF-b alone.
The additive nature of MMP-2 and TGF-b inhibition on H357
adhesion is interesting. These findings suggest that MMP-2 is
regulated by factors other than TGF-b and/or that MMP-2 and
TGF-b are targeting different keratinocyte adhesion molecules.
MMPs-3, -7 and -9, for example, cleave the ectodomain of
E-cadherin leading to inhibition of intercellular adhesion (Noë
et al, 2001; Orlichenko and Radisky, 2008). Further, MMP-2/9
cleave Desmoglein 3 (DSG3), a type I integral membrane
glycoproteins that belong to the Cadherin family of calcium-
dependent cell adhesion molecules, in skin blistering disorders
(Weiske et al, 2001; Cirillo et al, 2007c). DSG3 is the main desmo-
cadherin expressed by keratinocyte monolayers in vitro (Koch et al,
1992; Denning et al, 1998) and is found in all cell layers of oral
mucosal epithelium in vivo (Mahoney et al, 1999). With respect to
TGF-b, recent studies have shown that CAF-derived TGF-b can
induce an epithelial–mesenchymal transition in breast cancer cells
(Yu et al, 2014), and the cytokine is known to promote tissue repair
and fibrosis in myofibroblasts via the focal adhesion kinase (FAK)
pathway (Leask, 2012). Whether senescent CAF-derived TGF-b
regulates keratinocyte adhesion through FAK, however, is
unknown. The findings illustrate the complexity of stromal–
epithelial interactions. Not only do constituents of the SASP
interact directly with malignant keratinocytes to modulate cell
behaviour but they also appear to interact with one another and
with other components of the tumour microenvironment.
MMPs are regulated precisely during synthesis and secretion, at
the time of activation of the pro-enzyme and/or by localisation,
clearance and inhibition of the active enzyme (Ra and Parks, 2007).
With respect to activation, previous studies have shown that
MMP-2 is activated by osteopontin (Zhang et al, 2011), reactive
oxygen species (ROS; Svineng et al, 2008), TGF-b2 (Baumann et al,
2009) and TIMP-2 (Itoh et al, 2001; Rosenthal and Matrisian,
2006), among other mechanisms. It is particularly interesting,
therefore, that osteopontin is a key constituent of the SASP (Coppé
et al, 2008) and is known to promote epithelial tumour
development (Pazolli et al, 2009). In addition, we have demon-
strated that malignant keratinocytes from GU-OSCC induce
senescence in normal fibroblasts in a ROS- and TGF-b-dependent
manner (Hassona et al, 2013). Further, we have shown that
radiation-induced fibroblast senescence is associated with
increased TIMP-1 and TIMP-2, and both TIMP-1 and TIMP-2
are increased in the media of fibroblast cultures from patients with
the premalignant condition oral sub-mucous fibrosis where
senescent cells are more abundant (Pitiyage et al, 2012). It may
be, therefore, that the activation of MMP-2 is a key event in
mediating the effects of CAFs on epithelial malignancy. The role of
MMP-2, however, is complex. On the one hand, the enzyme
appears to cause epithelial dis-cohesion and promote epithelial
invasion in vitro, while on the other, we and others have shown
that fibroblast-derived MMP-2 may ameliorate excessive fibrosis
by degrading collagen (Jun and Lau, 2010; Pitiyage et al, 2011).
Further studies are undergoing in our labs to clarify the
role of MMPs in relation to the epithelial dis-cohesive effects
of CAFs.
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